1. Home
  2. MBIO vs OBLG Comparison

MBIO vs OBLG Comparison

Compare MBIO & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • OBLG
  • Stock Information
  • Founded
  • MBIO 2015
  • OBLG 2000
  • Country
  • MBIO United States
  • OBLG United States
  • Employees
  • MBIO N/A
  • OBLG N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • MBIO Health Care
  • OBLG Technology
  • Exchange
  • MBIO Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • MBIO 4.7M
  • OBLG 5.5M
  • IPO Year
  • MBIO N/A
  • OBLG N/A
  • Fundamental
  • Price
  • MBIO $1.91
  • OBLG $4.16
  • Analyst Decision
  • MBIO
  • OBLG
  • Analyst Count
  • MBIO 0
  • OBLG 0
  • Target Price
  • MBIO N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • MBIO 17.7M
  • OBLG 140.0K
  • Earning Date
  • MBIO 08-12-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • MBIO N/A
  • OBLG N/A
  • EPS Growth
  • MBIO N/A
  • OBLG N/A
  • EPS
  • MBIO N/A
  • OBLG N/A
  • Revenue
  • MBIO N/A
  • OBLG $2,374,000.00
  • Revenue This Year
  • MBIO N/A
  • OBLG N/A
  • Revenue Next Year
  • MBIO N/A
  • OBLG N/A
  • P/E Ratio
  • MBIO N/A
  • OBLG N/A
  • Revenue Growth
  • MBIO N/A
  • OBLG N/A
  • 52 Week Low
  • MBIO $0.89
  • OBLG $1.91
  • 52 Week High
  • MBIO $21.95
  • OBLG $7.20
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 49.43
  • OBLG 46.49
  • Support Level
  • MBIO $1.97
  • OBLG $4.57
  • Resistance Level
  • MBIO $2.12
  • OBLG $5.50
  • Average True Range (ATR)
  • MBIO 0.33
  • OBLG 0.60
  • MACD
  • MBIO -0.08
  • OBLG -0.08
  • Stochastic Oscillator
  • MBIO 0.26
  • OBLG 21.18

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: